Drugs / Bupivicaine
Trials 21
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT06293807 | Jun 2022 → Apr 2023 | periodontal disorder | The University of Texas Health Science Center at San Antonio | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT02862691 | Aug 2016 → Aug 2017 | — | Stony Brook University | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT01444924 | Sep 2011 → Feb 2013 | female reproductive organ cancer | University of Wisconsin, Madison | Completed | No outcome recorded |
| Phase 2 | NCT00930072 | Apr 2009 → Dec 2014 | intracranial vasospasm | University of Washington | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT00280553 | Apr 2005 → Apr 2013 | — | Margherita CADDEDU | Unknown | No outcome recorded |
| Phase 49 trials · 1 met primary · 2 missed | ||||||
| Phase 4 | NCT04364867 | Aug 2020 → Feb 2021 | — | Norton Healthcare | Completed | No outcome recorded |
| Phase 4 | NCT04663269 | Feb → Sep 2020 | urolithiasis | Indiana University | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT02865928 | Sep 2017 → Nov 2019 | — | Northwell Health | Terminated | No outcome recorded |
| Phase 4 | NCT02474654 | Jul 2015 → Jan 2019 | — | Health Sciences North Research Institute | Completed | No outcome recorded |
| Phase 4 | NCT02497911 | Jan 2014 → Nov 2015 | — | Thomas Jefferson University | Unknown | No outcome recorded |
| Phase 4 | NCT02055053 | Aug 2013 → Oct 2019 | — | Lahey Clinic | Completed | Missed primary |
| Phase 4 | NCT01267825 | Sep 2010 → Aug 2013 | lumbar disk disease, radiculopathy | Montefiore Medical Center | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT00915473 | Jun 2009 → Jan 2013 | migraine disorder | Mayo Clinic | Completed | Missed primary |
| Phase 4 | NCT00533845 | Sep 2007 → Jan 2010 | — | Maimonides Medical Center | Completed | Met primary |
| Phase not applicable7 trials | ||||||
| — | NCT02604589 | Mar → Nov 2016 | — | Anthony Iacco | Terminated | No outcome recorded |
| — | NCT02483689 | Aug 2015 → Jul 2020 | appendicitis | Valley Anesthesiology Consultants | Unknown | No outcome recorded |
| — | NCT02399800 | Dec 2014 → Feb 2018 | chronic pancreatitis | University of Southern California | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT01480102 | Aug 2011 → Aug 2020 | — | Loyola University | Unknown | No outcome recorded |
| — | NCT00810914 | Mar 2006 → Jun 2010 | — | MemorialCare | Unknown | No outcome recorded |
| — | NCT00178178 | Mar 2005 → Nov 2007 | neuropathy, painful | University of Rochester | Completed | No outcome recorded |
| — | NCT00500565 | Dec 2003 → Jun 2006 | breast cancer | M.D. Anderson Cancer Center | Completed | No outcome recorded |
| Comparator or background therapy23 trials | ||||||
| Phase 1 | NCT04011098 Comparator | Jul 2019 → Nov 2020 | obstetric disorder | University of Saskatchewan | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT03122301 Comparator | Jun 2017 → Jul 2020 | — | Northwestern University | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT02513329 Comparator | Jul 2015 → Jan 2020 | flushing of ears and somnolence | Northwestern University | Completed | No outcome recorded |
| Phase 3 | NCT02466022 Background | Jun → Nov 2015 | — | University of Saskatchewan | Completed | No outcome recorded |
| Phase 3 | NCT00658736 Comparator | Mar 2008 → Jan 2011 | chronic pancreatitis | The Cleveland Clinic | Completed | No outcome recorded |
| Phase 3 | NCT00398866 Comparator | Aug 2006 → Mar 2013 | osteoarthritis | Hospital for Special Surgery, New York | Completed | No outcome recorded |
| Phase 4 | NCT05338671 Comparator | Sep 2021 → Jun 2024 | pulpitis | University of Washington | Completed | No outcome recorded |
| Phase 4 | NCT04575688 Comparator | Jul 2021 → Sep 2026 overdue | — | Campbell Clinic | Enrolling by invitation | No outcome recorded |
| Phase 4 | NCT04114058 Comparator | Oct 2019 → Mar 2020 | — | Cedars-Sinai Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT02662036 Comparator | Feb 2016 → Feb 2018 | — | Washington University School of Medicine | Terminated | Missed primary |
| Phase 4 | NCT04743986 Comparator | Mar 2015 → Jun 2019 | rotator cuff syndrome | University of Calgary | Completed | No outcome recorded |
| Phase 4 | NCT02784340 Comparator | May 2014 → Dec 2015 | — | Cairo University | Completed | No outcome recorded |
| — | NCT06155097 Comparator | Dec 2023 → Apr 2024 | cardiac valvular defect | Zagazig University | Unknown | No outcome recorded |
| — | NCT05975294 Comparator | Aug 2023 → Aug 2024 | — | Sohag University | Unknown | No outcome recorded |
| — | NCT03540095 Background | Jul 2018 → May 2019 | neurological pain disorder | University of Pittsburgh | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT02197988 Comparator | Dec 2013 → Aug 2016 | — | Corewell Health West | Completed | No outcome recorded |
| — | NCT01452633 Comparator | Nov 2011 → May 2014 | — | Stony Brook University | Unknown | No outcome recorded |
| — | NCT01916590 Comparator | Jul 2011 → May 2014 | — | University of Colorado, Denver | Terminated | No outcome recorded |
| — | NCT01303003 Background | Dec 2010 → Nov 2012 | prostate cancer | Steward St. Elizabeth's Medical Center of Boston, Inc. | Completed | No outcome recorded |
| — | NCT00928564 Comparator | Apr 2009 → Dec 2015 | levator syndrome | University of California, Irvine | Completed | No outcome recorded |
| — | NCT00644111 Comparator | Feb 2008 → Jul 2011 | — | University Health Network, Toronto | Completed | No outcome recorded |
| — | NCT00329732 Comparator | Mar → Apr 2006 | migraine disorder | Thomas Jefferson University | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT00203294 Comparator | Jun 2005 → Jun 2006 | migraine disorder | Thomas Jefferson University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 44 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bupivicaine | “The Control group will receive a 2 ml bolus of standard epidural mix solution (0.08% Bupivicaine with 2 mcg/ml Fentanyl) after epidural placement followed by standard care...” NCT04011098 ↗43“Participants in this arm will receive an inferior alveolar nerve block with 1 cartridge (1.8 mL) of 0.5% bupivicaine 1:200,000 epinephrine following endodontic treatment.” NCT05338671 ↗ “8ml of 0.5% bupivicaine, 1ml of 10mg/ml triamcinolone, 1ml of 8.4% sodium bicarbonate for a total volume of 10ml. Five ml will be used at each block site.” NCT00928564 ↗ “administration of 20 ml volume of local anesthetics (Lidocaine 2% +Bupivicaine 0.5% 1:1 mixture + 8mg dexamethasone) on each side” NCT06155097 ↗ “A total of 0.5 mL/kg of 0.25% Bupivicaine or saline, up to a maximum of 30 cc, will be injected using a 22g needle.” NCT02483689 ↗ “analgesic provided in the erector spinae block is 20mL of 0.5% Bupivicaine with 4mg of PF Dexamethasone” NCT04663269 ↗ “Bupivicaine 0.5% without epinephrine (100mg)20cc will be injected into the T10 paravertebral space.” NCT01480102 ↗ “Bupivicaine .375% via on-Q pump will be infused at a rate of 2cc/hr intraperitoneally” NCT00533845 ↗ “Bupivicaine 0.0625% will be used for continuous infusion of local anesthetic.” NCT03540095 ↗ “Single shot Exparel 10cc (133mg) mixed with 10cc of 0.5% Bupivicaine” NCT04364867 ↗ “40 cc. 0.125% bupivicaine + 0.5cc. dexamethasone (2mg.) per side.” NCT01303003 ↗ |
| Modality | Other / unclassified | “local anesthetic” NCT00280553 ↗ |
| Route | Other | “intraarticular infusion” NCT00178178 ↗ |